Cargando…

General treatment for metastatic colorectal cancer: From KEYNOTE 177 study

In the palliative treatment of metastatic colorectal cancer (mCRC), doublet chemotherapy (FOLFOX or FOLFIRI) or triplet chemotherapy (FOLFOXIRI) combined with targeted drugs (cetuximab or bevacizumab) is the main regimen. Recently, microsatellite instability-high (MSI-H) or DNA mismatch repair defic...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ding, Yuwei, Weng, Shanshan, Li, Xinyu, Zhang, Ding, Aisa, Adilai, Yuan, Ying
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Neoplasia Press 2021
Materias:	Spotlight
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8144732/ https://www.ncbi.nlm.nih.gov/pubmed/34030111 http://dx.doi.org/10.1016/j.tranon.2021.101122

Ejemplares similares

Immunogenomics of Colorectal Cancer Response to Checkpoint Blockade: Analysis of the KEYNOTE 177 Trial and Validation Cohorts
por: Bortolomeazzi, Michele, et al.
Publicado: (2021)

Comprehensive Analysis of the Brain-Expressed X-Link Protein Family in Glioblastoma Multiforme
por: Aisa, Adilai, et al.
Publicado: (2022)

Harnessing the therapeutic vulnerability of MMR heterogeneity in colorectal cancer
por: Anandappa, Gayathri, et al.
Publicado: (2023)

CSCO guidelines for metastatic colorectal cancer: personalized medicine in clinical practice
por: Yang, Mengyuan, et al.
Publicado: (2023)

A polarized anchor for hematopoietic stem cells: Synapse between stem cells and their niche?
por: Lee, Yeojin, et al.
Publicado: (2021)

Localised ABA signalling mediates root growth plasticity
por: Ding, Zhaojun, et al.
Publicado: (2013)

Immunotherapy combined with local therapy in the late-line treatment of repair-proficient (pMMR)/microsatellite stable (MSS) metastatic colorectal cancer
por: Ding, Yuwei, et al.
Publicado: (2023)

Phylogenomics of Elongate-Bodied Springtails Reveals Independent Transitions from Aboveground to Belowground Habitats in Deep Time
por: Yu, Daoyuan, et al.
Publicado: (2022)

PSMA diagnostics and treatments of prostate cancer become mature
por: von Eyben, Finn Edler, et al.
Publicado: (2018)

Cross communication of diet-microbiome-immune interactions in cancer immunotherapy
por: Zhou, Cheng-Bei, et al.
Publicado: (2022)

Lessons from early life: understanding development to expand stem cells and treat cancers
por: Bain, Fiona M., et al.
Publicado: (2022)

From bugs to drugs: Bacterial 3-IAA enhances efficacy of chemotherapy in pancreatic cancer
por: Seo, Y. David, et al.
Publicado: (2023)

Right in time: Mitapivat for the treatment of anemia in α- and β-thalassemia
por: Musallam, Khaled M., et al.
Publicado: (2022)

Long noncoding RNA amplified in lung cancer rewires cancer pathways
por: Martínez-Terroba, Elena, et al.
Publicado: (2020)

The double face of cold in cancer
por: Voskarides, Konstantinos
Publicado: (2022)

Timing is everything: Clinical evidence supports pre-symptomatic treatment for spinal muscular atrophy
por: Motyl, Anna A.L., et al.
Publicado: (2022)

The ongoing mystery of renal cell cancer
por: Yang, James C.
Publicado: (2021)

FGF21 regulates alcohol intake: New hopes on the rise for alcohol use disorder treatment?
por: Wang, Tammy, et al.
Publicado: (2022)

Cancer Patients and Risk of Mortality for COVID-19
por: Curigliano, Giuseppe
Publicado: (2020)

Alarming increase of NASH as cause of liver cancer
por: Craciun, Ana, et al.
Publicado: (2022)

Air pollution, EGFR mutation, and cancer initiation
por: Han, Si-Chong, et al.
Publicado: (2023)

Successful treatment of lead‐related superior vena cava syndrome in combination with transvenous lead extraction and venous stenting
por: Iwakawa, Hidehiro, et al.
Publicado: (2023)

ARF3 weights the balance for prostate cancer metastasis
por: Caswell, Patrick T.
Publicado: (2023)

Precision oncology for upper GI cancers – Where are we heading?
por: Quante, Michael
Publicado: (2021)

When blockchain meets artificial intelligence: An application to cancer histopathology
por: Hong, Runyu, et al.
Publicado: (2022)

Two types of biomarker-dependent chemo-immunotherapy for pancreatic cancer?
por: Melief, Cornelis J.M.
Publicado: (2022)

Chromosome-level genome editing uncovers aneuploidy addiction in cancer
por: O’Brien, Siobhan, et al.
Publicado: (2023)

Complete revascularization in elderly patients with myocardial infarction—a safe, effective, and necessary strategy?
por: Gue, Ying X., et al.
Publicado: (2023)

Transition metal ion-doped ferrites nanoparticles for bioimaging and cancer therapy
por: Du, Hui, et al.
Publicado: (2021)

Frequent His‐Purkinje discharges with longitudinal dissociation in a case with multiple premature ventricular contractions suppressed by co‐treatment with verapamil and quinidine
por: Suzuki, Keisuke, et al.
Publicado: (2022)

Keynotes
Publicado: (2023)

Optimizing hormone therapy for breast cancer: Translating gains to the early-stage setting
por: Chien, A. Jo, et al.
Publicado: (2022)

Trastuzumab deruxtecan: An antibody-drug conjugate embracing its destiny in breast cancer
por: Makhlin, Igor, et al.
Publicado: (2022)

Why the complications of COVID-19 patients differ in elderly and young cancer patients
por: Bravaccini, Sara, et al.
Publicado: (2022)

Neoadjuvant therapy gains FDA approval in non-small cell lung cancer
por: Leal, Ticiana A., et al.
Publicado: (2022)

Ventricular tachycardia because of myocardial infarction after COVID‐19 vaccination
por: Lee, Dan‐Ying, et al.
Publicado: (2022)

CD8(+) T cells: An ineffective armor against prolonged COVID-19 in cancer patients
por: Van Oekelen, Oliver, et al.
Publicado: (2022)

Organoids as a tool in drug discovery and patient-specific therapy for head and neck cancer
por: Done, Aaron J., et al.
Publicado: (2023)

Anti-PD-L1 plus enzalutamide does not improve overall survival in prostate cancer
por: Siddiqui, Bilal A., et al.
Publicado: (2022)

Decrypting the potency of anti-cancer therapeutics by using mass spectrometry to quantify post-translational modifications
por: Herbst, Sophie A., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_hk14fd7mh2j5rkvffng8aj0d4b